The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

THURSDAY, June 12, 2025 (HealthDay News) — A newly approved shot could soon help protect babies from respiratory syncytial ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

The Serum Institute of India collaborates with the Drugs for Neglected Diseases initiative to develop a monoclonal antibody ...

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

Recent innovations across the multiple ADC components, such as enhanced antibody-targeting to the tumors, better linker ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

The collaboration will focus on advancing the potential drug candidate—formerly known as VIS513—through Phase III clinical ...

Study reveals the advantages and pitfalls of adding a TKI to a monoclonal antibody after chemoradiation for non-small cell ...